Eli Lilly currently trades at $1,061 and has been a dream stock for shareholders. It’s returned 541% since December 2020, blowing past the S&P 500’s 85.2% gain. The company has also beaten the index ...

Former President Barack Obama and Michelle Obama’s media company Higher Ground has acquired Sam Fragoso’s podcast “Talk Easy.” As the weekly podcast enters its tenth year, Fragoso will bring his ...

Lily Collins has penned an emotional note for her Emily in Paris fans. Ahead of the season 5 of Netflix show, Collins took to Instagram and shared photos from the premiere night. Alongside the photos, ...

Most people assume high-paying jobs come with long hours and constant stress, but that's not always the case. In fact, there are several roles that offer both solid income and a healthy dose of down ...

Len Yaffee, Kessef Capital, join 'Fast Money' to talk Amgen's obesity drug, Eli Lilly's current stock action, and much more. Trump Revokes TPS, Citing Fraud Concerns 'Satanist' actor jailed for ...

Eli Lilly and Co (NYSE: LLY) shares are trading higher on Friday. The company plans to start selling its obesity drug through a new approach aimed at expanding access. What To Know: Eli Lilly is ...

When the idea of having integrated resorts (IRs) with legalised casinos was mooted in 2004 by then Prime Minister Lee Hsien Loong as part of the competitive remaking of Singapore, ministers and MPs ...

Fashion brands Lilly Pulitzer and Dee Ocleppo have collaborated on a limited-edition capsule collection. The collection is described as a "love letter to Palm Beach" and features two new prints. Dee ...

INDIANAPOLIS (WISH) — Bloomington recently hosted a display of Jim Irsay’s legendary guitar collection, featuring iconic instruments from music history. The Jim Irsay Guitar Collection, featuring ...

A companion novel to the brilliant Writers & Lovers, this delightfully witty tale of college romance matures into midlife poignancy The university experience is a risky business in fiction. Generally, ...

Eli Lilly & Co. raised its full-year guidance as revenue from its blockbuster weight loss and diabetes drugs beat expectations in the third quarter and it began solidifying its lead over its biggest ...